16:08 EST BridgeBio (BBIO) Pharma trading halted, news pending
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- BridgeBio Pharma call volume above normal and directionally bullish
- BridgeBio reports open-label extension data on acoramidis in ATTR-CM
- BridgeBio announces publication of PROPEL 2 data in NEJM
- BridgeBio price target raised to $45 from $44 at Scotiabank
- BridgeBio Pharma Reports Quarterly Loss Amid Restructuring